Detailed answers about IKSIRA PHARMACEUTICALS LTD, including incorporation, status, business activity, and accounts information.
When was IKSIRA PHARMACEUTICALS LTD founded?
IKSIRA PHARMACEUTICALS LTD was officially incorporated on 15 July 2025 and is registered under company number 16583770. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is IKSIRA PHARMACEUTICALS LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of IKSIRA PHARMACEUTICALS LTD?
IKSIRA PHARMACEUTICALS LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does IKSIRA PHARMACEUTICALS LTD do?
IKSIRA PHARMACEUTICALS LTD operates in the following sectors: 46450 - Wholesale of perfume and cosmetics, 46460 - Wholesale of pharmaceutical goods, 47749 - Retail sale of medical and orthopaedic goods in specialised stores (not incl. hearing aids) n.e.c., 47750 - Retail sale of cosmetic and toilet articles in specialised stores. These SIC codes provide insight into the company's business activities and industry focus.
What is IKSIRA PHARMACEUTICALS LTD's registered address?
The registered office address of IKSIRA PHARMACEUTICALS LTD is 71-75 SHELTON STREET, COVENT GARDEN, LONDON, UNITED KINGDOM, WC2H 9JQ. This is the official address filed with Companies House for legal and statutory correspondence.
Is IKSIRA PHARMACEUTICALS LTD financially stable?
Financial accounts for IKSIRA PHARMACEUTICALS LTD are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.